Genentech to Present at 2015 COPD & Asthma Conference on Biomarker … – Lung Disease News

Genentech to Present at 2015 COPD & Asthma Conference on Biomarker
Lung Disease News
Biotechnology company Genentech has been invited to present at the 11th Asthma & COPD conference, an annual event that will gather some of the most internationally prominent scientists, clinicians and industry leaders to discuss the latest findings on …

View full post on asthma – Google News

Top 10 Reasons to Go to the 11th Asthma & COPD Conference in April 2015 – Lung Disease News


Lung Disease News

Top 10 Reasons to Go to the 11th Asthma & COPD Conference in April 2015
Lung Disease News
This year's Asthma & COPD 2015 will be held at the Holiday Inn Regent's Park Hotel between April 13 and 14, 2015 in London, United Kingdom, and will include prominent scientists, clinicians and industry leaders who will gather to discuss the latest

and more »

View full post on asthma – Google News

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD – RTT News


Monthly Prescribing Reference

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 6 news articles »

View full post on asthma – Google News

New Inhalers for Asthma, COPD Launched – Monthly Prescribing Reference


Monthly Prescribing Reference

New Inhalers for Asthma, COPD Launched
Monthly Prescribing Reference
GlaxoSmithKline announced the launch of Arnuity Ellipta (fluticasone furoate inhalation powder) and Incruse Ellipta (umeclidinium bromide inhalation powder). Arnuity Ellipta is an inhaled corticosteroid indicated for the maintenance treatment of asthma
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
GSK expands its portfolio of medicines in the US for patients with asthma and MarketWatch

all 6 news articles »

View full post on asthma – Google News